Kevin Choe, M.D., Ph.D.
“Brain cancer is an area that desperately needs new, improved treatments,” says Assistant Professor of Radiation Oncology Kevin Choe, M.D., Ph.D. “I hope to make a contribution by using my training and insight in clinical oncology and cancer biology.”
Dr. Choe is an award-winning physician and scientist who devotes his time both to patient care in the clinic and scientific research in the lab. He is particularly interested in understanding the molecular triggers that cause brain tumors. Dr. Choe was also the lead investigator of a study that made headlines recently, showing a possible link between taking aspirin and improved outcomes in prostate cancer.
With today’s improvements in radiation delivery and image guidance, we can deliver a more powerful, ablative dose, which should result in better outcomes for patients.
“My patients are fighting a tough battle against cancer,” says Dr. Choe. “They motivate me to go the extra mile in trying to help them in this fight.”
Dr. Choe is part of the neuro-oncology team at UT Southwestern, and his expertise includes stereotactic radiosurgery using Gamma Knife and CyberKnife to treat primary tumors in the brain as well as brain metastases. He is board certified in radiation oncology and has both contributed to and served as a reviewer of multiple scientific journals.
His current research, funded by UT Southwestern and the American Brain Tumor Association, seeks to understand why some cancers of the central nervous system become resistant to radiation therapy. He has also developed a screening process to identify genes that may be involved in brain cancer development and progression.